Iterum Therapeutics Plc (ITRM) Return on Investment ROI from the third quarter of 2025 to third quarter of 2024 and for the year 2025, average high and low, overall ranking from Sep 30 2025 to Sep 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Iterum Therapeutics Plc  (NASDAQ: ITRM)


Iterum Therapeutics Plc's ROI from its third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Iterum Therapeutics Plc's ROI in the third quarter of 2025?
Iterum Therapeutics Plc recorded a cumulative net loss of $-27 million during 12 months ending in the third quarter of 2025, resulting in a negative return on investment (ROI) of -97.25%.

Within the Healthcare sector 602 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2025 from 3562 to 3938.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Investment Change TTM - 1534.95 % -3.93 % - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 26 28 29 27 -12
Return On Investment (TTM) -97.25 % -131.36 % -265.98 % 6732.07 % -
ITRM's Overall Ranking # 3938 # 3562 # 2780 # 1759 # 4209
Seq. Investment Change TTM 51.26 % 116.05 % - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -27 -24 -23 -25 -31

ITRM Company Profile >> Back to ITRM Roi Comparisons >> See Annual ITRM Return On Investment



Return On Investment ITRM's Ranking
Within: No.
Industry # 271
Sector # 603
Overall # 3938

Return On Investment Statistics
High Average Low
5.06 %
-276.67 %
-1385.51 %
(Mar 31 2022)   (Mar 31 2021)







Financial Statements
Iterum Therapeutics Plc's III. Quarter Investments $ 26 Millions ITRM's Balance sheet
Iterum Therapeutics Plc's III. Quarter Income $ -9 Millions Quarterly ITRM's Income Statement
ITRM's Income by Division See ITRM's Income by Division


ITRM Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 27 5 39 61 -22
Y / Y Investment Growth 415.27 % -86.7 % -34.99 % - -
Net Income in Millions -25 -38 -44 -92 -52
Y / Y Net Income Growth - - - - -
Annual Return On Investment -91.79 % -732.55 % -112.79 % -151.1 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ITRM's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ITRM's Competitors
Subscribers only: Roi for Iterum Therapeutics Plc's Suppliers
Subscribers only: Return On Investment for ITRM's Customers

Other Ratios
ITRM's Roa ITRM's Inventory Turnover Ratio ITRM's Growth Rates ITRM's Dividend Statistics
ITRM's Profitability Ratios ITRM's Asset Turnover Ratio ITRM's Dividend Growth
ITRM's Roe ITRM's Valuation Ratios ITRM's Financial Strength Ratios ITRM's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2025, within Healthcare Sector ROI

Date modified: 2026-09-26T07:34:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.